Breast Carcinoma by Gene Expression Profile

Breast Carcinoma by Gene Expression Profile — Trials · CancerIndex

Clinical trials

Registered studies

1,299 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 537
Recruiting: 296
Ph III recruiting: 38
Growth YoY: +1.9%
Industry share: 28%
Top sponsor: Fudan University
Termination share: 46%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (217)

clinicaltrialsPublishedShowing 201–250 of 304 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06817525	Nab-P+Cb+PD1 Inhibitors as Neoadjuvant Therapy for Early TNBC	recruiting	Phase 2	64	Henan Cancer HospitalOTHER_GOV	1	Dec 5, 2025	clinicaltrials
NCT05076682	Reverse Triple Negative Immune Resistant Breast Cancer(Renaissance)	recruiting	Phase 2	80	Fudan UniversityOTHER	1	Dec 3, 2025	clinicaltrials